data_1trf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1trf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.096 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -136.03 104.94 5.86 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.6 pp -149.4 150.24 32.1 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.804 0.811 . . . . 0.0 110.276 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -85.02 112.59 20.75 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -103.35 -40.62 6.31 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.15 -53.4 55.95 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 120.128 1.331 . . . . 0.0 114.051 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -70.44 -38.38 74.51 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 117.073 -1.441 . . . . 0.0 114.156 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.8 -48.04 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-N 121.276 1.853 . . . . 0.0 110.874 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.75 -35.64 74.99 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -71.25 -40.71 70.85 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-N 119.215 0.916 . . . . 0.0 112.895 174.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -59.39 -48.16 82.7 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 119.597 1.09 . . . . 0.0 111.728 171.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -59.45 -37.28 77.74 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 172.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.63 -48.02 81.2 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.73 86.89 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 171.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -60.79 -56.31 22.76 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.331 1.452 . . . . 0.0 113.738 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.13 -32.38 72.07 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 52.8 ttm -64.77 -47.86 76.59 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-N 119.548 1.067 . . . . 0.0 111.899 170.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -92.69 60.88 3.55 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.971 0.908 . . . . 0.0 111.281 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.12 133.12 34.5 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -173.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.01 -58.14 2.42 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.68 169.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.9 -63.29 1.44 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 124.038 0.935 . . . . 0.0 110.366 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.73 -83.11 0.08 OUTLIER Glycine 0 N--CA 1.481 1.672 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -131.01 74.91 0.43 Allowed Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.401 -1.879 . . . . 0.0 108.401 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.95 -58.09 0.06 OUTLIER Glycine 0 CA--C 1.541 1.667 0 CA-C-O 118.532 -1.149 . . . . 0.0 114.018 -175.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.98 139.89 52.71 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 118.277 1.039 . . . . 0.0 110.506 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.4 pt -116.32 161.66 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.6 m -69.61 167.36 17.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.996 -1.065 . . . . 0.0 113.778 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.799 ' CG2' ' CA ' ' A' ' 71' ' ' GLY . 22.3 p -63.06 -48.02 80.46 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.152 0.981 . . . . 0.0 112.798 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.93 -36.19 82.68 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 119.204 0.911 . . . . 0.0 113.375 172.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' O ' ' CG2' ' A' ' 44' ' ' THR . 60.7 mt-10 -63.06 -20.97 65.84 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-O 117.219 -1.372 . . . . 0.0 114.675 173.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 tt -59.7 -51.14 71.06 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 121.296 1.862 . . . . 0.0 110.84 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.05 -40.71 95.9 Favored Glycine 0 CA--C 1.555 2.537 0 CA-C-O 118.474 -1.181 . . . . 0.0 115.752 170.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 41' ' ' GLU . 10.1 t -58.89 -53.09 62.28 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 118.946 1.373 . . . . 0.0 113.278 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.0 m -58.23 -43.96 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 34.0 mtt -53.41 -44.67 68.91 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 171.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -60.74 -46.58 89.89 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 119.932 1.242 . . . . 0.0 113.305 172.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 27.1 ttt -57.13 -43.72 82.65 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.05 -74.2 0.2 Allowed 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.042 0.937 . . . . 0.0 110.612 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.88 71.91 0.03 OUTLIER Glycine 0 CA--C 1.54 1.636 0 CA-C-N 119.02 0.827 . . . . 0.0 112.061 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -168.06 125.02 1.1 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -77.41 121.98 85.3 Favored Pre-proline 0 CA--C 1.579 2.072 0 CA-C-O 117.651 -1.166 . . . . 0.0 110.284 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.26 89.46 1.08 Allowed 'Trans proline' 0 CA--C 1.56 1.791 0 C-N-CA 122.756 2.304 . . . . 0.0 111.551 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.1 t -81.82 166.2 20.2 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.644 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.84 -44.72 82.4 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 176.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.5 -44.0 83.78 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 119.147 0.885 . . . . 0.0 113.102 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.28 -54.97 37.26 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 119.399 1.0 . . . . 0.0 112.668 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.7 mt -56.0 -50.56 70.51 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 117.493 -1.241 . . . . 0.0 113.47 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.7 -54.36 42.78 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 119.763 1.165 . . . . 0.0 113.499 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.0 -30.6 69.25 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.02 -54.16 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 116.178 -1.868 . . . . 0.0 110.809 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.271 0.2 OUTLIER -70.99 -33.35 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 CA-C-N 123.179 2.718 . . . . 0.0 113.755 -178.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -68.84 -46.89 67.38 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -77.21 -56.8 4.25 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.658 0.783 . . . . 0.0 111.129 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.7 t -90.08 104.38 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -57.99 163.06 2.95 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 117.524 2.416 . . . . 0.0 117.524 -172.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.452 ' OE1' ' CG2' ' A' ' 39' ' ' THR . 29.6 mm-40 -102.83 121.07 41.73 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -46.23 -52.69 12.01 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.35 -109.6 3.24 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 174.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.1 t -95.64 -72.99 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.799 ' CA ' ' CG2' ' A' ' 39' ' ' THR . . . -126.4 77.37 0.39 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 172.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 p -153.05 98.11 2.26 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.8 tp -82.46 138.29 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 124.177 0.991 . . . . 0.0 110.768 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -110.56 154.5 23.64 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.718 0.77 . . . . 0.0 112.35 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.6 -25.18 64.4 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 119.721 3.23 . . . . 0.0 119.721 -170.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -64.93 -67.04 0.47 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 121.291 1.86 . . . . 0.0 111.068 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -61.23 -37.61 83.65 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 174.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -55.74 -53.04 61.53 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.405 1.482 . . . . 0.0 113.472 171.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.6 tp -65.27 -34.35 78.13 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 117.985 -1.007 . . . . 0.0 113.441 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.0 t -62.43 -52.31 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 120.436 1.471 . . . . 0.0 111.076 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -35.43 76.41 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 177.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.6 ttt -74.68 -38.63 62.35 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 119.604 1.093 . . . . 0.0 113.804 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.51 -47.19 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-N 120.814 1.643 . . . . 0.0 111.007 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -66.69 -45.04 80.12 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -71.41 -70.39 0.32 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 120.039 1.291 . . . . 0.0 110.752 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 19.5 ptm -94.51 91.5 6.64 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.8 tttp . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 122.763 1.268 . . . . 0.0 110.512 -174.822 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.096 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -136.03 104.94 5.86 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.6 pp -149.4 150.24 32.1 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.804 0.811 . . . . 0.0 110.276 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -85.02 112.59 20.75 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -103.35 -40.62 6.31 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.15 -53.4 55.95 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 120.128 1.331 . . . . 0.0 114.051 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -70.44 -38.38 74.51 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 117.073 -1.441 . . . . 0.0 114.156 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.8 -48.04 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-N 121.276 1.853 . . . . 0.0 110.874 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.75 -35.64 74.99 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -71.25 -40.71 70.85 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-N 119.215 0.916 . . . . 0.0 112.895 174.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -59.39 -48.16 82.7 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 119.597 1.09 . . . . 0.0 111.728 171.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -59.45 -37.28 77.74 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 172.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.63 -48.02 81.2 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.73 86.89 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 171.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -60.79 -56.31 22.76 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.331 1.452 . . . . 0.0 113.738 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.13 -32.38 72.07 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 52.8 ttm -64.77 -47.86 76.59 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-N 119.548 1.067 . . . . 0.0 111.899 170.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -92.69 60.88 3.55 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.971 0.908 . . . . 0.0 111.281 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.12 133.12 34.5 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -173.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.01 -58.14 2.42 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.68 169.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.9 -63.29 1.44 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 124.038 0.935 . . . . 0.0 110.366 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.73 -83.11 0.08 OUTLIER Glycine 0 N--CA 1.481 1.672 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -131.01 74.91 0.43 Allowed Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.401 -1.879 . . . . 0.0 108.401 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.95 -58.09 0.06 OUTLIER Glycine 0 CA--C 1.541 1.667 0 CA-C-O 118.532 -1.149 . . . . 0.0 114.018 -175.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.98 139.89 52.71 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 118.277 1.039 . . . . 0.0 110.506 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.4 pt -116.32 161.66 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.6 m -69.61 167.36 17.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.996 -1.065 . . . . 0.0 113.778 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.989 HG23 ' C ' ' A' ' 71' ' ' GLY . 22.3 p -63.06 -48.02 80.46 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.152 0.981 . . . . 0.0 112.798 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.93 -36.19 82.68 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 119.204 0.911 . . . . 0.0 113.375 172.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.978 ' HA ' HG22 ' A' ' 44' ' ' THR . 60.7 mt-10 -63.06 -20.97 65.84 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-O 117.219 -1.372 . . . . 0.0 114.675 173.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 tt -59.7 -51.14 71.06 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 121.296 1.862 . . . . 0.0 110.84 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.05 -40.71 95.9 Favored Glycine 0 CA--C 1.555 2.537 0 CA-C-O 118.474 -1.181 . . . . 0.0 115.752 170.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.978 HG22 ' HA ' ' A' ' 41' ' ' GLU . 10.1 t -58.89 -53.09 62.28 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 118.946 1.373 . . . . 0.0 113.278 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.0 m -58.23 -43.96 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 34.0 mtt -53.41 -44.67 68.91 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 171.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -60.74 -46.58 89.89 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 119.932 1.242 . . . . 0.0 113.305 172.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 27.1 ttt -57.13 -43.72 82.65 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.05 -74.2 0.2 Allowed 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.042 0.937 . . . . 0.0 110.612 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.88 71.91 0.03 OUTLIER Glycine 0 CA--C 1.54 1.636 0 CA-C-N 119.02 0.827 . . . . 0.0 112.061 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -168.06 125.02 1.1 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -77.41 121.98 85.3 Favored Pre-proline 0 CA--C 1.579 2.072 0 CA-C-O 117.651 -1.166 . . . . 0.0 110.284 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.26 89.46 1.08 Allowed 'Trans proline' 0 CA--C 1.56 1.791 0 C-N-CA 122.756 2.304 . . . . 0.0 111.551 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.682 HG23 ' H ' ' A' ' 57' ' ' GLU . 10.1 t -81.82 166.2 20.2 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.644 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.84 -44.72 82.4 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 176.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.5 -44.0 83.78 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 119.147 0.885 . . . . 0.0 113.102 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.682 ' H ' HG23 ' A' ' 54' ' ' THR . 33.8 tt0 -61.28 -54.97 37.26 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 119.399 1.0 . . . . 0.0 112.668 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.7 mt -56.0 -50.56 70.51 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 117.493 -1.241 . . . . 0.0 113.47 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.7 -54.36 42.78 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 119.763 1.165 . . . . 0.0 113.499 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.0 -30.6 69.25 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.02 -54.16 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 116.178 -1.868 . . . . 0.0 110.809 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.271 0.2 OUTLIER -70.99 -33.35 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 CA-C-N 123.179 2.718 . . . . 0.0 113.755 -178.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -68.84 -46.89 67.38 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -77.21 -56.8 4.25 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.658 0.783 . . . . 0.0 111.129 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.7 t -90.08 104.38 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -57.99 163.06 2.95 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 117.524 2.416 . . . . 0.0 117.524 -172.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.86 ' OE1' HG22 ' A' ' 39' ' ' THR . 29.6 mm-40 -102.83 121.07 41.73 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -46.23 -52.69 12.01 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.35 -109.6 3.24 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 174.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.1 t -95.64 -72.99 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.989 ' C ' HG23 ' A' ' 39' ' ' THR . . . -126.4 77.37 0.39 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 172.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 p -153.05 98.11 2.26 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.8 tp -82.46 138.29 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 124.177 0.991 . . . . 0.0 110.768 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -110.56 154.5 23.64 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.718 0.77 . . . . 0.0 112.35 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.458 ' HA ' ' HB3' ' A' ' 78' ' ' PHE . 5.6 t80 -59.6 -25.18 64.4 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 119.721 3.23 . . . . 0.0 119.721 -170.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -64.93 -67.04 0.47 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 121.291 1.86 . . . . 0.0 111.068 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -61.23 -37.61 83.65 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 174.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 75' ' ' PHE . 35.2 t80 -55.74 -53.04 61.53 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.405 1.482 . . . . 0.0 113.472 171.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.6 tp -65.27 -34.35 78.13 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 117.985 -1.007 . . . . 0.0 113.441 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.0 t -62.43 -52.31 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 120.436 1.471 . . . . 0.0 111.076 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -35.43 76.41 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 177.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.6 ttt -74.68 -38.63 62.35 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 119.604 1.093 . . . . 0.0 113.804 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.51 -47.19 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-N 120.814 1.643 . . . . 0.0 111.007 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -66.69 -45.04 80.12 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -71.41 -70.39 0.32 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 120.039 1.291 . . . . 0.0 110.752 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 19.5 ptm -94.51 91.5 6.64 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.8 tttp . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 122.763 1.268 . . . . 0.0 110.512 -174.822 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.096 0 CA-C-O 118.604 -0.712 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -136.03 104.94 5.86 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.6 pp -149.4 150.24 32.1 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.804 0.811 . . . . 0.0 110.276 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.8 m -85.02 112.59 20.75 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -103.35 -40.62 6.31 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.15 -53.4 55.95 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 120.128 1.331 . . . . 0.0 114.051 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -70.44 -38.38 74.51 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 117.073 -1.441 . . . . 0.0 114.156 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.6 mp -61.8 -48.04 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 CA-C-N 121.276 1.853 . . . . 0.0 110.874 175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.75 -35.64 74.99 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -71.25 -40.71 70.85 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-N 119.215 0.916 . . . . 0.0 112.895 174.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -59.39 -48.16 82.7 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 119.597 1.09 . . . . 0.0 111.728 171.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -59.45 -37.28 77.74 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 172.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.63 -48.02 81.2 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.73 86.89 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 171.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -60.79 -56.31 22.76 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.331 1.452 . . . . 0.0 113.738 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.13 -32.38 72.07 Favored 'General case' 0 CA--C 1.571 1.767 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 52.8 ttm -64.77 -47.86 76.59 Favored 'General case' 0 CA--C 1.57 1.733 0 CA-C-N 119.548 1.067 . . . . 0.0 111.899 170.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -92.69 60.88 3.55 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.971 0.908 . . . . 0.0 111.281 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.12 133.12 34.5 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -173.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.01 -58.14 2.42 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.68 169.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.9 -63.29 1.44 Allowed 'General case' 0 CA--C 1.57 1.712 0 C-N-CA 124.038 0.935 . . . . 0.0 110.366 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.73 -83.11 0.08 OUTLIER Glycine 0 N--CA 1.481 1.672 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -131.01 74.91 0.43 Allowed Glycine 0 N--CA 1.481 1.654 0 N-CA-C 108.401 -1.879 . . . . 0.0 108.401 173.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.95 -58.09 0.06 OUTLIER Glycine 0 CA--C 1.541 1.667 0 CA-C-O 118.532 -1.149 . . . . 0.0 114.018 -175.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.98 139.89 52.71 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 118.277 1.039 . . . . 0.0 110.506 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.4 pt -116.32 161.66 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 66.6 m -69.61 167.36 17.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.996 -1.065 . . . . 0.0 113.778 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.989 HG23 ' C ' ' A' ' 71' ' ' GLY . 22.3 p -63.06 -48.02 80.46 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.152 0.981 . . . . 0.0 112.798 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.93 -36.19 82.68 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 119.204 0.911 . . . . 0.0 113.375 172.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.978 ' HA ' HG22 ' A' ' 44' ' ' THR . 60.7 mt-10 -63.06 -20.97 65.84 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-O 117.219 -1.372 . . . . 0.0 114.675 173.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 tt -59.7 -51.14 71.06 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 121.296 1.862 . . . . 0.0 110.84 169.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.05 -40.71 95.9 Favored Glycine 0 CA--C 1.555 2.537 0 CA-C-O 118.474 -1.181 . . . . 0.0 115.752 170.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.978 HG22 ' HA ' ' A' ' 41' ' ' GLU . 10.1 t -58.89 -53.09 62.28 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 118.946 1.373 . . . . 0.0 113.278 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.0 m -58.23 -43.96 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 34.0 mtt -53.41 -44.67 68.91 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 171.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -60.74 -46.58 89.89 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 119.932 1.242 . . . . 0.0 113.305 172.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 27.1 ttt -57.13 -43.72 82.65 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.05 -74.2 0.2 Allowed 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 124.042 0.937 . . . . 0.0 110.612 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.88 71.91 0.03 OUTLIER Glycine 0 CA--C 1.54 1.636 0 CA-C-N 119.02 0.827 . . . . 0.0 112.061 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -168.06 125.02 1.1 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -77.41 121.98 85.3 Favored Pre-proline 0 CA--C 1.579 2.072 0 CA-C-O 117.651 -1.166 . . . . 0.0 110.284 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.26 89.46 1.08 Allowed 'Trans proline' 0 CA--C 1.56 1.791 0 C-N-CA 122.756 2.304 . . . . 0.0 111.551 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.682 HG23 ' H ' ' A' ' 57' ' ' GLU . 10.1 t -81.82 166.2 20.2 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.644 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.84 -44.72 82.4 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 176.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.5 -44.0 83.78 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 119.147 0.885 . . . . 0.0 113.102 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.682 ' H ' HG23 ' A' ' 54' ' ' THR . 33.8 tt0 -61.28 -54.97 37.26 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 119.399 1.0 . . . . 0.0 112.668 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.7 mt -56.0 -50.56 70.51 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 117.493 -1.241 . . . . 0.0 113.47 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.7 -54.36 42.78 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 119.763 1.165 . . . . 0.0 113.499 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.0 -30.6 69.25 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.02 -54.16 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 116.178 -1.868 . . . . 0.0 110.809 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.271 0.2 OUTLIER -70.99 -33.35 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 CA-C-N 123.179 2.718 . . . . 0.0 113.755 -178.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -68.84 -46.89 67.38 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -77.21 -56.8 4.25 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.658 0.783 . . . . 0.0 111.129 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.7 t -90.08 104.38 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -57.99 163.06 2.95 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 117.524 2.416 . . . . 0.0 117.524 -172.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.86 ' OE1' HG22 ' A' ' 39' ' ' THR . 29.6 mm-40 -102.83 121.07 41.73 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -46.23 -52.69 12.01 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.35 -109.6 3.24 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 174.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.1 t -95.64 -72.99 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.989 ' C ' HG23 ' A' ' 39' ' ' THR . . . -126.4 77.37 0.39 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 172.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 p -153.05 98.11 2.26 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.8 tp -82.46 138.29 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 124.177 0.991 . . . . 0.0 110.768 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -110.56 154.5 23.64 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.718 0.77 . . . . 0.0 112.35 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.458 ' HA ' ' HB3' ' A' ' 78' ' ' PHE . 5.6 t80 -59.6 -25.18 64.4 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 119.721 3.23 . . . . 0.0 119.721 -170.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -64.93 -67.04 0.47 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 121.291 1.86 . . . . 0.0 111.068 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -61.23 -37.61 83.65 Favored 'General case' 0 CA--C 1.574 1.883 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 174.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 75' ' ' PHE . 35.2 t80 -55.74 -53.04 61.53 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.405 1.482 . . . . 0.0 113.472 171.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.6 tp -65.27 -34.35 78.13 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 117.985 -1.007 . . . . 0.0 113.441 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.0 t -62.43 -52.31 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 120.436 1.471 . . . . 0.0 111.076 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -35.43 76.41 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 177.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.6 ttt -74.68 -38.63 62.35 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 119.604 1.093 . . . . 0.0 113.804 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.51 -47.19 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-N 120.814 1.643 . . . . 0.0 111.007 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -66.69 -45.04 80.12 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -71.41 -70.39 0.32 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 120.039 1.291 . . . . 0.0 110.752 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 19.5 ptm -94.51 91.5 6.64 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.8 tttp . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 122.763 1.268 . . . . 0.0 110.512 -174.822 . . . . . . . . 0 0 . 1 stop_ save_